Redcare Pharmacy NV (RDC) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.044x

Based on the latest financial reports, Redcare Pharmacy NV (RDC) has a cash flow conversion efficiency ratio of 0.044x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€20.70 Million ≈ $24.20 Million USD) by net assets (€468.30 Million ≈ $547.49 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Redcare Pharmacy NV to measure how many days the company can operate on defensive assets alone.

Redcare Pharmacy NV - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Redcare Pharmacy NV's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Redcare Pharmacy NV Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Redcare Pharmacy NV ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Kunshan Guoli Electronic Technology Co Ltd SHG:688103	0.012x
Jiangsu Hongdou Industrial Co Ltd SHG:600400	0.003x
Hana Materials Inc KQ:166090	0.064x
Huachangda Intelligent Equipment Group Co Ltd SHE:300278	0.035x
E2E Networks Limited NSE:E2E	0.020x
LGI Homes NASDAQ:LGIH	0.041x
Zhengping Road&Bridge Constr SHG:603843	-0.011x
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A SHE:301408	N/A

Annual Cash Flow Conversion Efficiency for Redcare Pharmacy NV (2013–2025)

The table below shows the annual cash flow conversion efficiency of Redcare Pharmacy NV from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see Redcare Pharmacy NV (RDC) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€479.20 Million ≈ $560.24 Million	€23.00 Million ≈ $26.89 Million	0.048x	+10.62%
2024-12-31	€509.97 Million ≈ $596.21 Million	€22.13 Million ≈ $25.87 Million	0.043x	-61.03%
2023-12-31	€552.03 Million ≈ $645.38 Million	€61.46 Million ≈ $71.85 Million	0.111x	+235.61%
2022-12-31	€354.63 Million ≈ $414.60 Million	€-29.11 Million ≈ $-34.03 Million	-0.082x	-393.10%
2021-12-31	€415.41 Million ≈ $485.66 Million	€11.63 Million ≈ $13.60 Million	0.028x	-33.11%
2020-12-31	€425.14 Million ≈ $497.03 Million	€17.80 Million ≈ $20.81 Million	0.042x	+132.10%
2019-12-31	€232.76 Million ≈ $272.12 Million	€-30.37 Million ≈ $-35.50 Million	-0.130x	-18.58%
2018-12-31	€213.98 Million ≈ $250.16 Million	€-23.54 Million ≈ $-27.52 Million	-0.110x	-13.11%
2017-12-31	€238.97 Million ≈ $279.38 Million	€-23.24 Million ≈ $-27.17 Million	-0.097x	+47.26%
2016-12-31	€93.25 Million ≈ $109.01 Million	€-17.20 Million ≈ $-20.11 Million	-0.184x	+94.83%
2015-12-31	€2.46 Million ≈ $2.87 Million	€-8.78 Million ≈ $-10.26 Million	-3.570x	-1844.15%
2014-12-31	€20.06 Million ≈ $23.45 Million	€-3.68 Million ≈ $-4.31 Million	-0.184x	+21.73%
2013-12-31	€18.08 Million ≈ $21.14 Million	€-4.24 Million ≈ $-4.96 Million	-0.235x	--

About Redcare Pharmacy NV

XETRA:RDC Germany Pharmaceutical Retailers

Market Cap

$1.60 Billion

€1.37 Billion EUR

Market Cap Rank

#9526 Global

#1172 in Germany

Share Price

€67.15

Change (1 day)

+4.19%

52-Week Range

€30.86 - €112.40

All Time High

€246.00